Tolerability and safety aspects of mirtazapine
- PMID: 12404669
- DOI: 10.1002/hup.388
Tolerability and safety aspects of mirtazapine
Abstract
The tolerability and safety profile of the noradrenergic and specific serotonergic antidepressant (NaSSA) mirtazapine reflects its unique pharmacological profile. The 5-HT(2) blocking effect contributes towards its anxiolytic effects and benefits on sleep, as well as preventing the sexual dysfunction that may occur with non-specific stimulation of the serotonin system by drugs such as the selective serotonin reuptake inhibitors (SSRIs). In addition, 5-HT(3) blockade by mirtazapine helps to prevent nausea and vomiting. Weight gain is the most commonly reported side-effect of mirtazapine, although there is evidence to suggest that this is not a significant problem during long-term treatment. In conclusion, mirtazapine has a good tolerability and safety profile that demonstrates several benefits over other antidepressants.
Copyright 2002 John Wiley & Sons, Ltd.
Similar articles
-
Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.Depress Anxiety. 1998;7 Suppl 1:7-10. Depress Anxiety. 1998. PMID: 9597345 Review.
-
The pharmacologic profile of mirtazapine.J Clin Psychiatry. 1996;57 Suppl 4:19-25. J Clin Psychiatry. 1996. PMID: 8636062 Review.
-
Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects.Pharmacotherapy. 1997 Jan-Feb;17(1):10-21. Pharmacotherapy. 1997. PMID: 9017762 Review.
-
Mirtazapine: a newer antidepressant.Am Fam Physician. 1999 Jan 1;59(1):159-61. Am Fam Physician. 1999. PMID: 9917581 Review.
-
Mirtazapine: pharmacology in relation to adverse effects.Acta Psychiatr Scand Suppl. 1997;391:31-7. doi: 10.1111/j.1600-0447.1997.tb05956.x. Acta Psychiatr Scand Suppl. 1997. PMID: 9265949
Cited by
-
Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.CNS Drugs. 2005;19(2):137-46. doi: 10.2165/00023210-200519020-00004. CNS Drugs. 2005. PMID: 15697327 Clinical Trial.
-
Mirtazapine versus Megestrol in the Treatment of Anorexia-Cachexia Syndrome in Patients with Advanced Cancer: A Randomized, Double-Blind, Controlled Phase II Clinical Trial.Cancers (Basel). 2023 Jul 12;15(14):3588. doi: 10.3390/cancers15143588. Cancers (Basel). 2023. PMID: 37509249 Free PMC article.
-
Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.Clin Drug Investig. 2016 Oct;36(10):783-9. doi: 10.1007/s40261-016-0433-8. Clin Drug Investig. 2016. PMID: 27401779 Review.
-
An in vitro comparison of microdialysis relative recovery of Met- and Leu-enkephalin using cyclodextrins and antibodies as affinity agents.Anal Chim Acta. 2008 Jul 14;620(1-2):170-5. doi: 10.1016/j.aca.2008.05.028. Epub 2008 May 21. Anal Chim Acta. 2008. PMID: 18558138 Free PMC article.
-
Trazodone once-a-day: A formula for addressing challenges in antidepressant safety and tolerability.Neurosci Appl. 2023 May 22;2:101127. doi: 10.1016/j.nsa.2023.101127. eCollection 2023. Neurosci Appl. 2023. PMID: 40655971 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical